NetMedi develops Kaiku® Health, a web-based platform that collects and analyzes patient-reported outcomes to enable personalized, data-driven cancer care. The software provides secure online communication between patients and care teams and a real-time dashboard for clinicians to improve outcome-driven care. Kaiku® Health supports several treatment options across nine common cancer types, including breast, prostate, melanoma, liver, bile duct, pancreas, colorectal, lymphomas and head and neck. The platform was developed in close cooperation with patients, cancer researchers, clinics, doctors and nurses and is designed to enhance daily clinical routines. NetMedi counts 17 clinics as clients in Finland, Sweden and Switzerland. The company reported a 70% organic revenue increase last year and plans to use recent funding to accelerate expansion across Europe.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2016